Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A mesenchymal chondrosarcoma occurring in adults.
Biomarker and diagnostic research for adult mesenchymal chondrosarcoma has been reported in the published literature.
No clinical trials have been registered for adult mesenchymal chondrosarcoma.
45 publications have been identified in PubMed for adult mesenchymal chondrosarcoma. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (16%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 | 31% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC
Common questions about adult mesenchymal chondrosarcoma
Research summaries
7 |
16% |
Clinical study results | 7 | 16% |
Laboratory research | 7 | 16% |
Disease patterns and progression | 6 | 13% |
Testing and diagnosis research | 3 | 7% |
New treatment approaches | 1 | 2% |
Ichikawa J (2026). [PMID: 41941232](https://pubmed.ncbi.nlm.nih.gov/41941232/). *Clin Nucl Med*. [Case Report / Case Series]
Çalışkan Kamış Ş (2026). [PMID: 41867924](https://pubmed.ncbi.nlm.nih.gov/41867924/). *Front Pediatr*. [Case Report / Case Series]
Qin XF (2026). [PMID: 41644428](https://pubmed.ncbi.nlm.nih.gov/41644428/). *Zhonghua Bing Li Xue Za Zhi*. [Basic Science / Preclinical]
Trecourt A (2026). [PMID: 41255082](https://pubmed.ncbi.nlm.nih.gov/41255082/). *The American journal of surgical pathology*. [Basic Science / Preclinical]
Nishio J (2026). [PMID: 41760307](https://pubmed.ncbi.nlm.nih.gov/41760307/). *In vivo (Athens, Greece)*. [Clinical Trial Publication]
Nagy A (2026). [PMID: 41930936](https://pubmed.ncbi.nlm.nih.gov/41930936/). *Adv Anat Pathol*. [Diagnostic / Biomarker]
Shamsi ZA (2025). [PMID: 39865287](https://pubmed.ncbi.nlm.nih.gov/39865287/). *Journal of cardiothoracic surgery*. [Clinical Trial Publication]
Ioakeim-Ioannidou M (2025). [PMID: 39303998](https://pubmed.ncbi.nlm.nih.gov/39303998/). *International journal of radiation oncology, biology, physics*. [Clinical Trial Publication]
Lin JQ (2025). [PMID: 40301759](https://pubmed.ncbi.nlm.nih.gov/40301759/). *BMC ophthalmology*. [Epidemiology / Natural History]
Masunaga T (2025). [PMID: 40613902](https://pubmed.ncbi.nlm.nih.gov/40613902/). *International orthopaedics*. [Clinical Trial Publication]
AI-curated news mentioning adult mesenchymal chondrosarcoma
Updated Feb 5, 2026
A multicentre retrospective analysis by the Italian Sarcoma Group evaluates the activity of chemotherapy in mesenchymal chondrosarcoma. This study provides insights into treatment efficacy for this rare sarcoma subtype.